Myocardial Infarction
3 competing products in clinical development for Myocardial Infarction.
Pipeline by Phase
Pre-clinical1
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abciximab | Eli Lilly | Approved | Completed | 43 |
| Prasugrel + Clopidogrel | Daiichi Sankyo | Phase 3 | Completed | 40 |
| Half-dose of the Tc99-m sestamibi (Cardiolite) | Astellas Pharma | Pre-clinical | Terminated | 18 |